Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.